(UroToday.com) The 2024 South Central AUA annual meeting included a session on lower genitourinary tract cancer, featuring a presentation by Clare Weiland discussing whether the use of continuous ...

The use of prophylactic tranexamic acid didn't lead to a reduction in blood transfusion for patients undergoing open radical cystectomy for bladder cancer. The use of prophylactic tranexamic acid did ...

Oct 18 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Friday it was voluntarily withdrawing its drug, Trodelvy, for patients with a type of bladder cancer after it failed to meet the ...

The move is a blow to Gilead’s cancer portfolio. Trodelvy, an antibody-drug conjugate granted accelerated approval for bladder cancer in 2021, failed its confirmatory trial earlier this year. Gilead ...

The withdrawal in metastatic urothelial carcinoma, an aggressive form of bladder cancer, does not affect the drug’s status in its other approved indications in the U.S. or other markets.

With this paper we aim to confirm the potential effect of bladder irrigation on the urothelium by means of a complete histological and immunohistochemical study on bladder specimens in an 85 year ...

We believe that the irrigation of the bladder induced the urothelium disruption leading to a massive fluid absorption (approximately 5 liters), responsible for the serious hemodynamic effects ...